USPTO 2015–2025 USPTO PatentsView US Corporation

Cardiac Pacemakers, Inc.

USPTO PatentsView assignee record — 1,178 granted patents across 81 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

1,178
Total patents granted
81
CPC technology areas
17.9
Avg claims per patent
-37%
5-year filing velocity

Portfolio overview

Cardiac Pacemakers, Inc. has been granted 1,178 US utility patents between 2015 and 2025, placing Cardiac Pacemakers, Inc. at rank #369 across all assignees tracked by PlainPatent. This portfolio spans 81 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Cardiac Pacemakers, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 64.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 457 grants, compared with 721 in the 2015–2019 window — a -37% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cardiac Pacemakers, Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 81 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cardiac Pacemakers, Inc. against peers pursuing similar technology classes.

How does Cardiac compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Cardiac holds 1,178 patents — placing it at rank #369 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

050100150200250 20152016201720182019202020212022202320242025 23
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cardiac Pacemakers, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 193 16.4%
2016 159 13.5%
2017 153 13.0%
2018 90 7.6%
2019 126 10.7%
2020 121 10.3%
2021 109 9.3%
2022 99 8.4%
2023 63 5.3%
2024 42 3.6%
2025 23 2.0%

Which technologies does Cardiac Pacemakers, Inc. patent most?

Top 15 of 81 technology areas

Patent Moat Analysis

Portfolio Volume Strong
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#369

Across all tracked assignees

Innovation Score

64.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cardiac Pacemakers, Inc. hold?
Cardiac Pacemakers, Inc. holds 1,178 US granted patents filed between 2015 and 2025, spanning 81 technology areas.
What is Cardiac Pacemakers, Inc.'s Innovation Score?
Cardiac Pacemakers, Inc. has an Innovation Score of 64.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Cardiac Pacemakers, Inc. focus on?
Cardiac Pacemakers, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 1,037 patents. The company has filed patents in 81 CPC subclasses total.
Is Cardiac Pacemakers, Inc.'s patent filing rate increasing or decreasing?
Cardiac Pacemakers, Inc.'s recent filing velocity is -37% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Cardiac Pacemakers, Inc.'s patents?
Cardiac Pacemakers, Inc.'s patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Cardiac Pacemakers, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope